Fiat Chrysler Automobiles ("FCA") (NYSE: FCAU MTA: FCA) announced today that the Company is continuing its review of the potential separation of FCA's subsidiary Magneti Marelli S.p.A. ("Magneti Marelli")
The Board of Directors of the Company plans to review in detail options relating to this transaction in the second quarter of 2018, concurrent with the Board's review of the Group's 2018-2022 business plan. In the meantime management will continue its evaluation of potential transaction structures to maximize value to FCA stockholders.
There is no assurance that the review of the potential separation of Magneti Marelli will result in a final determination to enter into any such transaction or that such transaction, if commenced, will be completed. FCA does not intend to make any further disclosures concerning these matters until a definitive determination is made.
London, 28 February 2018
This press release contains forward-looking statements. These statements are based on the FCA group's current expectations and projections about future events and, by their nature, are subject to inherent risks and uncertainties. They relate to events and depend on circumstances that may or may not occur or exist in the future and, as such, undue reliance should not be placed on them. Actual results may differ materially from those expressed in such statements as a result of a variety of factors, including: volatility and deterioration of capital and financial markets, including possibility of new Eurozone sovereign debt crisis, changes in commodity prices, changes in general economic conditions, economic growth and other changes in business conditions, weather, floods, earthquakes or other natural disasters, changes in government regulation, production difficulties, including capacity and supply constraints, and many other risks and uncertainties, most of which are outside of the FCA group's control.
Attachment:
http://www.globenewswire.com/NewsRoom/AttachmentNg/27c14f93-cbe8-411d-a42c-d2cc7540b69e


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 



